Related Experiment Video
Updated: Mar 18, 2026
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Quantitative analyses of myelofibrosis by determining hydroxyproline
Wanke Zhao1, Wan-Ting Tina Ho1, Zhizhuang Joe Zhao1
1Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.
Background:
Myeloproliferative neoplasms (MPNs) are blood malignancies manifested in increased production of red blood cells, white blood cells, and/or platelets. Myelofibrosis is a subtype of MPNs characterized by the formation of scar-like tissues in the bone marrow due to abnormal hematopoiesis. It is considered a disease of both hematopoietic stem cells and stem cell niches. Patients with myelofibrosis have very poor prognosis, and there is no effective treatment so far. Myelofibrosis has routinely been detected by using histochemical staining methods which produce qualitative rather than quantitative results. In this study, we developed a quantitative assay of bone marrow myelofibrosis in JAK2V617F transgenic mice by determining hydroxyproline.
Methods:
The JAK2V617F transgenic mice's tissue was collected to detect the bone marrow myelofibrosis. Statistical analyses were performed using the GraphPad Prism program. Differences of samples between two groups were accessed using t tests. P values less than 0.05 (2-tailed) were considered significantly different.
Results:
We developed a quantitative method for detecting myelofibrosis by analyzing the content of hydroxyproline, a modified amino acid largely restricted to collagen which forms the fibrotic structure in bone marrow tissues. Our study also demonstrated age-dependent development of bone marrow myelofibrosis in JAK2V617F transgenic mice.
Conclusions:
In the present study, we have developed a new method for detecting bone marrow myelofibrosis by analyzing hydroxyproline contents. The method is highly sensitive and accurate. It provides more accurate, representative, and quantitative information than histochemical analyses. We believe that this method should find wide applications for analyzing the progression of myelofibrosis and efficacy of drug treatment.
Insights
Researchers developed a new quantitative assay for bone marrow myelofibrosis using hydroxyproline analysis in JAK2V617F mice. This method offers accurate, sensitive detection of fibrosis, improving upon qualitative histochemical staining for disease progression and treatment efficacy studies.
Area of Science:
- Hematology
- Oncology
- Biochemistry
Background:
- Myeloproliferative neoplasms (MPNs) are blood cancers involving overproduction of blood cells.
- Myelofibrosis, an MPN subtype, is characterized by bone marrow scarring and poor prognosis.
- Current detection methods for myelofibrosis are qualitative and lack precision.
Purpose of the Study:
- To develop a quantitative assay for bone marrow myelofibrosis.
- To utilize hydroxyproline content as a biomarker for fibrosis.
- To assess myelofibrosis development in JAK2V617F transgenic mice.
Main Methods:
- Bone marrow tissue from JAK2V617F transgenic mice was analyzed.
- Hydroxyproline content was quantified to assess fibrosis.
- Statistical analyses included t-tests for group comparisons.
Main Results:
- A novel quantitative method for detecting bone marrow myelofibrosis was established.
- Hydroxyproline analysis accurately reflects fibrotic tissue content.
- Age-dependent development of myelofibrosis was observed in the studied mice.
Conclusions:
- The developed hydroxyproline assay provides sensitive and accurate quantification of myelofibrosis.
- This method offers superior quantitative data compared to traditional histochemical analyses.
- The assay has potential applications in monitoring myelofibrosis progression and evaluating drug efficacy.
